This inventor holds 1 USPTO granted patent. Top assignee: Bio-Technology General Corporation. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Tikva Vogil: Innovator in Genetic Engineering
Introduction
Tikva Vogil is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of genetic engineering, particularly through his innovative patent work. His expertise and inventions have had a profound impact on biotechnology.
Latest Patents
Tikva Vogil holds a patent for "Expression vectors containing lambdapl promoter and T.sub.1 T.sub.2 rRNA." This improved vector, upon introduction into a suitable host containing the thermolabile repressor C.sub.I, enables the host to express a desired gene. The vector is a double-stranded DNA molecule that includes several key components, such as the promoter and operator P.sub.L O.sub.L from lambda bacteriophage, a ribosomal binding site, and a transcription termination sequence. The design of this vector allows for the production of important proteins, including bovine, chicken, and porcine growth hormones, as well as human apolipoprotein E and human superoxide dismutase.
Career Highlights
Tikva Vogil is associated with Bio-Technology General Corporation, where he has been instrumental in advancing biotechnological research and applications. His work has led to the development of innovative solutions in the field, showcasing his commitment to scientific progress.
Collaborations
Throughout his career, Tikva has collaborated with esteemed colleagues, including Amos B Oppenheim and Marian Gorecki. These partnerships have fostered a collaborative environment that enhances research and innovation.
Conclusion
Tikva Vogil's contributions to genetic engineering and biotechnology are noteworthy. His innovative patent and collaborative efforts continue to influence the field, demonstrating the importance of creativity and teamwork in scientific advancement.